BiOM is the leader in the field of personal bionics with the
introduction of the first powered prosthetic device, BiOM T2. Privately
held and headquartered in Bedford, Mass., BiOM was founded in 2007 by
Dr. Hugh Herr, Director and Principal Investigator of the
Biomechatronics Group of MIT's Media Laboratory, and funded by leading
investment firms including WFD Ventures, General Catalyst Partners,
Sigma Partners, and Gilde Healthcare Partners.
The BiOM T2 technology emulates muscle function by powering dorsi and
plantar flexion to allow people with lower leg amputations to walk with
a more normalized gait, using less energy to walk at a normal preferred
speed, and better able to navigate uneven terrain. These benefits may
potentially reduce musculoskeletal stress believed to be the cause of
co-morbidities associated with the use of prostheses including
osteoarthritis. The company received funding and support from the U.S.
Department of Veterans Affairs, and the U.S. Army's Telemedicine and
Advanced Technology Research Center (TATRC).
Type of Organization:
CEO: Charles Carignan
[ Back To NFVZone's Homepage ]